在严重喘中使用特泽佩卢马布的定位
J C Miralles-López1,2, D Antolín-Amérigo2,3,4, I García-Moguel2,5,6
1Allergy Department, Hospital General Universitario Reina Sofía, Murcia, Spain.
Journal of investigational allergology & clinical immunology
|October 9, 2023
概括
作为一种生物向胸膜 stromal lymphopoietin (TSLP) 的 Tezepelumab,通过减少恶化和改善症状,有效治疗严重的喘. 它在喘患者的TSLP相关炎症水平上提供了广泛的临床益处.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘影响3%-10%的患者,需要新的生物治疗.
- 目前的生物药物通过向特定的细胞因子或IgE来部分抑制2型 (T2) 炎症级联.
- 针对TSLP等上游分子,为复杂喘提供了更有效的治疗策略.
研究的目的:
- 审查tezepelumab的疗效和定位,这是一种新型的生物向胸膜 stromal lymphopoietin (TSLP).
- 评估tezepelumab对各种T2炎症概况的严重失控喘的影响.
- 评估tzepelumab在改善喘控制,生活质量和肺功能方面的作用.
主要方法:
- 佩鲁马布是一种针对TSLP的人类单克隆抗体,防止其与受体结合.
- 这项研究回顾了关于tzepelumab对生物标志物的作用和严重喘的临床结果的临床数据.
- 分析包括对T2炎症生物标志物 (乙素,FeNO,IgE,IL-5,IL-13) 和恶化率的影响.
主要成果:
- 泰泽佩卢马布可以降低下游的炎症生物标志物,包括血液和呼吸道的乙氨基酸,FeNO,IgE,IL-5和IL-13.
- 它显著降低了严重喘患者的年度喘恶化率,在T2高患者中效果更大.
- 临床益处包括改善喘控制,生活质量,肺功能和减少气道过敏反应.
结论:
- 捷佩卢马布是第一个针对上皮衍生细胞因子 (TSLP) 的生物药物,为严重喘提供了一种新的方法.
- 它在严重不受控制的喘频谱中表现出广泛的有效性,特别有利于T2高的内型.
- 德泽佩卢马布在治疗严重喘方面取得了重大进展,解决了超出当前疗法的未满足需求.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
317
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
317
01:19Antiasthma Drugs: Leukotriene Modifiers
330
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
330
01:20Asthma: Pathogenesis and Management
425
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
425
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K